260 likes | 490 Views
Blood Clot Formation. ATLAS ACS 2—TIMI 51 Design. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. APPRAISE-2. ATLAS-ACS TIMI 46. Newer Antiplatelet Agents. WOEST Efficacy End Points. WOEST Bleeding Events.
E N D